Therapy Areas: Oncology
4 July 2025 - Global biopharmaceutical company AstraZeneca (LSE/STO/NASDAQ:AZN) announced on Friday that it has received European Union approval for Imfinzi (durvalumab) as the first and only perioper...
4 July 2025 - INOVIO Pharmaceuticals Inc (Nasdaq:INO), a US-based biotechnology company involved in developing and commercialising DNA medicines to help treat and protect people from HPV-related disea...
4 July 2025 - India-based biosimilars company Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, announced on Thursday that the European Commission has granted marketing authorisation in the Euro...
3 July 2025 - Dizal (SSE:688192), a China-based biopharmaceutical company involved in developing novel medicines for the treatment of cancer and immunological diseases, announced on Wednesday that the...
2 July 2025 - RedHill Biopharma Ltd (NASDAQ: RDHL), an Israeli specialty biopharmaceutical company, announced on Tuesday the initiation of patient recruitment into the Phase 2 study evaluating the eff...
1 July 2025 -

Clinical stage immuno-oncology company Genenta Science SPA (NASDAQ: GNTA) on Tuesday announced long-term follow-up data from its gl...